Advertisement
UK markets close in 8 hours 4 minutes
  • FTSE 100

    8,154.67
    +10.54 (+0.13%)
     
  • FTSE 250

    19,902.82
    -62.57 (-0.31%)
     
  • AIM

    761.94
    +1.20 (+0.16%)
     
  • GBP/EUR

    1.1711
    +0.0003 (+0.02%)
     
  • GBP/USD

    1.2486
    -0.0010 (-0.08%)
     
  • Bitcoin GBP

    46,559.55
    -4,217.78 (-8.31%)
     
  • CMC Crypto 200

    1,256.97
    -82.10 (-6.09%)
     
  • S&P 500

    5,035.69
    -80.48 (-1.57%)
     
  • DOW

    37,815.92
    -570.17 (-1.49%)
     
  • CRUDE OIL

    81.06
    -0.87 (-1.06%)
     
  • GOLD FUTURES

    2,296.90
    -6.00 (-0.26%)
     
  • NIKKEI 225

    38,274.05
    -131.61 (-0.34%)
     
  • HANG SENG

    17,763.03
    +16.12 (+0.09%)
     
  • DAX

    17,932.17
    -186.15 (-1.03%)
     
  • CAC 40

    7,984.93
    -80.22 (-0.99%)
     

New Strong Buy Stocks for April 17th

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:

Byrna Technologies Inc. BYRN:  This non-lethal defense technology companyhas seen the Zacks Consensus Estimate for its current year earnings increasing 157.1% over the last 60 days.

Byrna Technologies Inc. Price and Consensus

Byrna Technologies Inc. Price and Consensus
Byrna Technologies Inc. Price and Consensus

Byrna Technologies Inc. price-consensus-chart | Byrna Technologies Inc. Quote

Y-mAbs Therapeutics, Inc. YMAB: This commercial-stage biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 42.7% over the last 60 days.

Y-mAbs Therapeutics, Inc. Price and Consensus

Y-mAbs Therapeutics, Inc. Price and Consensus
Y-mAbs Therapeutics, Inc. Price and Consensus

Y-mAbs Therapeutics, Inc. price-consensus-chart | Y-mAbs Therapeutics, Inc. Quote

ADVERTISEMENT

Sandstorm Gold Ltd. SAND: This gold royalty company has seen the Zacks Consensus Estimate for its current year earnings increasing 16.7% over the last 60 days.

Sandstorm Gold Ltd Price and Consensus

Sandstorm Gold Ltd Price and Consensus
Sandstorm Gold Ltd Price and Consensus

Sandstorm Gold Ltd price-consensus-chart | Sandstorm Gold Ltd Quote

Corcept Therapeutics Incorporated CORT: This pharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 27.8% over the last 60 days.

Corcept Therapeutics Incorporated Price and Consensus

Corcept Therapeutics Incorporated Price and Consensus
Corcept Therapeutics Incorporated Price and Consensus

Corcept Therapeutics Incorporated price-consensus-chart | Corcept Therapeutics Incorporated Quote

Enveric Biosciences, Inc. ENVB: This biotechnology company has seen the Zacks Consensus Estimate for its next year earnings increasing 25.6% over the last 60 days.

Enveric Biosciences, Inc. Price and Consensus

Enveric Biosciences, Inc. Price and Consensus
Enveric Biosciences, Inc. Price and Consensus

Enveric Biosciences, Inc. price-consensus-chart | Enveric Biosciences, Inc. Quote

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Corcept Therapeutics Incorporated (CORT) : Free Stock Analysis Report

Sandstorm Gold Ltd (SAND) : Free Stock Analysis Report

Y-mAbs Therapeutics, Inc. (YMAB) : Free Stock Analysis Report

Byrna Technologies Inc. (BYRN) : Free Stock Analysis Report

Enveric Biosciences, Inc. (ENVB) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research